Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

Blood Specimen Collection 11Radiosurgery 7Sentinel Lymph Node Biopsy 5Early Intervention, Educational 5Surveys and Questionnaires 4Standard of Care 4Practice Guidelines as Topic 4Methods 4Indocyanine Green 4Educational Status 4X-Rays 3Surgical Procedures, Operative 3Nivolumab 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Immunotherapy 3Cognitive Behavioral Therapy 3Biopsy 3pembrolizumab 2montanide ISA 51 2aldesleukin 2Tomography, X-Ray Computed 2Tomography, Emission-Computed 2Specimen Handling 2Radiotherapy 2Radiation 2Positron-Emission Tomography 2Palliative Care 2Observation 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Melanoma × Nurse Clinicians × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡